Safety of N-Acetylcysteine at High Doses in Chronic Respiratory Diseases: A Review

gan Calverley, Peter, Rogliani, Paola, Papi, Alberto
Cyhoeddwyd yn Drug Saf (2020)

Rate of Decline of FEV(1) as a Biomarker of Survival?

gan Papi, Alberto, Beghé, Bianca, Fabbri, Leonardo M.
Cyhoeddwyd yn Am J Respir Crit Care Med (2021)

Models of Respiratory Infections: Virus-Induced Asthma Exacerbations and Beyond

gan Saturni, Sara, Contoli, Marco, Spanevello, Antonio, Papi, Alberto
Cyhoeddwyd yn Allergy Asthma Immunol Res (2015)

The efficacy of extrafine beclomethasone dipropionate–formoterol fumarate in COPD patients who are not “frequent exacerbators”: a post hoc analysis of the FORWARD study

gan Singh, Dave, Vezzoli, Stefano, Petruzzelli, Stefano, Papi, Alberto
Cyhoeddwyd yn Int J Chron Obstruct Pulmon Dis (2017)

Pharmacokinetics and Safety of Single and Multiple Doses of Oral N-Acetylcysteine in Healthy Chinese and Caucasian Volunteers: An Open-Label, Phase I Clinical Study

gan Papi, Alberto, Di Stefano, Andrea F. D., Radicioni, Milko
Cyhoeddwyd yn Adv Ther (2020)

Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD

gan Scichilone, Nicola, Benfante, Alida, Morandi, Luca, Bellini, Federico, Papi, Alberto
Cyhoeddwyd yn Patient Relat Outcome Meas (2014)

Extrafine beclometasone diproprionate/formoterol fumarate: a review of its effects in chronic obstructive pulmonary disease

gan Singh, Dave, Corradi, Massimo, Spinola, Monica, Petruzzelli, Stefano, Papi, Alberto
Cyhoeddwyd yn NPJ Prim Care Respir Med (2016)

Mechanisms of rhinovirus-induced asthma

gan Papadopoulos, Nikolaos G, Papi, Alberto, Psarras, Stelios, Johnston, Sebastian L
Cyhoeddwyd yn Paediatr Respir Rev (2004)

Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations

gan Nicolini, Gabriele, Scichilone, Nicola, Bizzi, Andrea, Papi, Alberto, Fabbri, Leonardo M
Cyhoeddwyd 2008

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal

gan Vanfleteren, Lowie, Fabbri, Leonardo M, Papi, Alberto, Petruzzelli, Stefano, Celli, Bartolome
Cyhoeddwyd yn Int J Chron Obstruct Pulmon Dis (2018)

Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA

gan Singh, Dave, Fabbri, Leonardo M, Vezzoli, Stefano, Petruzzelli, Stefano, Papi, Alberto
Cyhoeddwyd yn Int J Chron Obstruct Pulmon Dis (2019)

Circulating neutrophils levels are a predictor of pneumonia risk in chronic obstructive pulmonary disease

gan Pascoe, Steven J., Papi, Alberto, Midwinter, Dawn, Lettis, Sally, Barnes, Neil
Cyhoeddwyd yn Respir Res (2019)

Models of infection and exacerbations in COPD

gan Papi, Alberto, Contoli, Marco, Gaetano, Caramori, Mallia, Patrick, Johnston, Sebastian L
Cyhoeddwyd yn Curr Opin Pharmacol (2007)

Management of chronic refractory cough in adults

gan Visca, Dina, Beghè, Bianca, Fabbri, Leonardo Michele, Papi, Alberto, Spanevello, Antonio
Cyhoeddwyd yn Eur J Intern Med (2020)

New drugs targeting Th2 lymphocytes in asthma

gan Caramori, Gaetano, Groneberg, David, Ito, Kazuhiro, Casolari, Paolo, Adcock, Ian M, Papi, Alberto
Cyhoeddwyd 2008

A randomized, double-blinded, double-dummy efficacy and safety study of budesonide–formoterol Spiromax® compared to budesonide–formoterol Turbuhaler® in adults and adolescents with...

gan Virchow, J. Christian, Rodriguez-Roisin, Roberto, Papi, Alberto, Shah, Tushar P., Gopalan, Gokul
Cyhoeddwyd yn BMC Pulm Med (2016)

Treatment strategies for asthma: reshaping the concept of asthma management

gan Papi, Alberto, Blasi, Francesco, Canonica, Giorgio Walter, Morandi, Luca, Richeldi, Luca, Rossi, Andrea
Cyhoeddwyd yn Allergy Asthma Clin Immunol (2020)

ICS/formoterol in the management of asthma in the clinical practice of pulmonologists: an international survey on GINA strategy

gan Cruz, Álvaro A., Barile, Sara, Nudo, Elena, Brogelli, Laura, Guller, Patricia, Papi, Alberto
Cyhoeddwyd yn Asthma Res Pract (2021)

Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trial

gan Papi, Alberto, Nicolini, Gabriele, Crimi, Nunzio, Fabbri, Leonardo, Olivieri, Dario, Rossi, Andrea, Paggiaro, Pierluigi
Cyhoeddwyd 2012

The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPD

gan Papi, Alberto, Jones, Paul W, Dalvi, Prashant S, McAulay, Kirsten, McIver, Tammy, Dissanayake, Sanjeeva
Cyhoeddwyd yn Int J Chron Obstruct Pulmon Dis (2015)